Allow local health facilities, not hospitals, to treat child pneumonia in developing countries

August 18, 2008

Allowing children with severe pneumonia to be treated at local, first-level facilities instead of hospitals means much higher proportions of children are treated correctly. These are the conclusions of authors of an Article published early Online in an upcoming edition of The Lancet.

The Intergrated Management of Childhood Illness (IMCI) guidelines, developed in the mid-1990s, recommend that children with severe pneumonia attend hospital. However, in many poorer settings, children who are referred do not attend hospital and do not receive adequate care. Dr Enayet Karim Chowdhury and Dr Shams El Arifeen, International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), and colleagues studied the safety and effectiveness of modified guidelines that allowed children to be treated locally in first-level facilities, with referral to hospital only for the most severe cases.

The study used 10 first-level health facilities in Matlab, rural Bangladesh, that had been using the previous IMCI guidelines, and assessed children from two cohorts. The first was 261 children who attended the facilities between May 2003 and April 2004, before implementation of the modified guidelines. Of these, 94% were referred to hospital, and only 36% ended up receiving the appropriate care, while 1.1% (three children) died. The second cohort contained 1271 children treated at the facilities post-implementation of the modified guidelines. Of these, only 8% were referred to hospital, and 90% received appropriate care, while the mortality was 0.6% (seven deaths). The authors conclude: "Local adaptation of the IMCI guidelines, with appropriate training and supervision, could allow safe and effective management of severe pneumonia, especially if compliance with referral is difficult because of geographic, financial, or cultural barriers."

In an accompanying Comment, Dr Igor Rudan, Croatian Centre for Global Health, University of Split Medical School, Croatia, and Dr Harry Campbell, University of Edinburgh Medical School, UK, say: "We welcome a substantial increase in investment in controlled trials in developing countries to address crucial gaps in information -- such as correct case management of severe pneumonia in children with HIV infection -- and in health-policy and systems research to identify effective ways to improve and scale up implementation of interventions against pneumonia."
-end-
Dr Enayet Chowdhury and Dr Shams El Arifeen, International Centre for Diarrhoeal Disease Research, Bangladesh T) +880 2 881 0115 E) shams@icddrb.org

Dr Igor Rudan, Croatian Centre for Global Health, University of Split Medical School, Croatia T) +385-91-3011-575 E) irudan@hotmail.com

http://press.thelancet.com/bangladeshfinal.pdf

Lancet

Related Pneumonia Articles from Brightsurf:

Vaccine proves effective against the most severe type of pneumonia
A pneumococcal vaccine was effective at protecting children in Laos against the most severe type of pneumonia, a new study has found.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

Elderly patients with pneumonia twice as likely to die as those with broken hips, yet underestimate the danger of pneumonia
Elderly patients who are hospitalised with pneumonia are twice as likely to die as those hospitalised with hip fractures -- yet many elderly people fail to accurately assess their risk of pneumonia, concludes research due to be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).

Pneumonia recovery reprograms immune cells of the lung
Researchers have determined that after lungs recover from infection, alveolar macrophages (immune cells that live in the lungs and help protect the lungs against infection) are different in multiple ways and those differences persist indefinitely.

Skin and mucous membrane lesions as complication of pneumonia
Painful inflammatory lesions of the skin and mucous membranes may occur in children who develop bacterial pneumonia.

Vaccine reduces likelihood of severe pneumonia
A new study has found severe pneumonia decreases by 35 per cent in children who receive a vaccine against a pneumonia-causing bacteria.

Bacteria in pneumonia attack using bleaching agent
Research shows that bacteria use hydrogen peroxide to weaken the immune system and cause pneumonia.

Many kids with pneumonia get unnecessary antibiotics, chest X-rays
Preschool children with community-acquired pneumonia often receive unnecessary tests and treatment at outpatient clinics and emergency departments, according to a nationally representative study led by Todd Florin, M.D., MSCE, from Ann & Robert H.

Certain psychiatric drugs linked with elevated pneumonia risk
A review of published studies indicates that use of benzodiazepines and benzodiazepine related drugs (BZRDs), which are prescribed to treat various psychiatric diseases, may increase the risk of pneumonia.

Bacterial pneumonia far more dangerous to the heart than viral pneumonia, study finds
Heart complications in patients diagnosed with bacterial pneumonia are more serious than in patients diagnosed with viral pneumonia, according to new research.

Read More: Pneumonia News and Pneumonia Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.